+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)

Archives

Loading Events

Women’s Health in Polycystic Kidney Disease (PKD) – A Focus on Pregnancy & Family Planning

Thank you for attending, we hope you enjoyed this webinar.

Please tell us what you thought about today’s presentation by taking the survey below:

Women’s Health in Polycystic Kidney Disease (PKD) – A Focus on Pregnancy & Family Planning

Background  

Women with ADPKD overall are as likely as the general population to have a successful pregnancy resulting in a live birth. Women with hypertension and ADPKD are more likely than normotensive women to develop pre-eclampsia, premature delivery, and low-birth-weight babies. All women with ADPKD who become pregnant should be medically managed by a multidisciplinary team including obstetricians and nephrologists.1 

Did You Know?  

While most women with ADPKD have safe pregnancies and healthy babies2, it is important for women with ADPKD and their care providers to be aware of the risks associated with pregnancy in ADPKD.  

Why Attend This Webinar?  

In this webinar, Dr. Niloofar Nobakht will provide an overview of ADPKD as a genetically inherited disease and describe the burden of ADPKD as it pertains to women of child-bearing potential. This webinar will provide insight into the challenges women with ADPKD face during pregnancy, including risks to both themselves as well as the baby. Dr. Nobakht will then describe general management principles for women with ADPKD to support a healthy pregnancy, as well as share options and resources for families with ADPKD planning to become pregnant.  

What You Will Learn: 

  1. ADPKD background and overview; including epidemiology, genetic pattern of inheritance, and disease burden 
  2. An overview of pregnancy in ADPKD; including the impact of ADPKD on family planning and pregnancy, as well as the impact of pregnancy on disease progression
  3. A review of the fetal and maternal complications that women with ADPKD face​, as well as an overview of general management strategies for ADPKD during pregnancy​
  4. Options and resources for families with ADPKD planning to become pregnant 
 

References 

  1. Sayyab MA, Chapman AC. Advances in Kidney Disease and Health. 2023; 30(5)  
  2. Pregnancy and PKD. https://pkdcure.org/living-with-pkd/pregnancy-and-pkd/. Accessed July 8, 2024. 

Speakers

Niloofar Nobakht

Niloofar Nobakht, MD

Associate Clinical Professor of Nephrology at UCLA
Executive Councilor for Women in Nephrology

Dr. Niloofar Nobakht is a Nephrology faculty member at UCLA. Her current research and practice are focused on Hypertension, Diabetes, and Polycystic Kidney Disease in patients with chronic kidney disease. She completed a kidney disease research fellowship at the University of Colorado Health Science Center in Denver and the Internal Medicine residency training at the University of Southern California.

She completed the Clinical Nephrology Fellowship at the David Geffen School of Medicine, Ronald Reagan UCLA Medical Center.

She is board certified and Faculty of the American Society of Nephrology, with several publications. She has participated in a wealth of research including hypertension, diabetes, polycystic kidney disease and kidney transplantation.

She highly supports the mission of kidney health awareness in our society in both the research and clinic field.

She is the founder of the Music and Kidney program and was awarded as wellness champion.

She highly supports the role of music and wellness on human health. She has been elected as an executive councilor at large for Women in Nephrology and is the lead councilor of the WIN Speaker Bureau.

Moderators

Marla Dallal

Marla Dallal, PharmD, RPH

Nephrology Senior Medical Science Liaison
Otsuka Pharmaceutical Development & Commercialization, Inc.*

Marla Dallal, PharmD, RPH is a Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization covering Southern California. She earned her Doctor of Pharmacy degree from the University of Southern California, School of Pharmacy in Los Angeles. While in pharmacy school, Dr Dallal pursued various clinical internships within the acute care and ambulatory care settings at Cedars-Sinai Medical Center and Kaiser Permanente. Prior to joining Otsuka, Dr Dallal held various positions within Medical Affairs at Amgen Inc covering the cardiometabolic and nephrology therapeutic areas. She also served as a preceptor at Amgen Inc, where she instructed pharmacy students on Advanced Pharmacy Practice rotations. She is currently licensed as a pharmacist in the state of California with the National Association Board of Pharmacy.

Sushma Shiravanthe

Sushma Shiravanthe, PharmD, BCPS

Nephrology Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Sushma Shiravanthe, PharmD, BCPS, is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) covering Northern California. Dr. Shiravanthe earned her BS in Brain, Behavior, and Cognitive Science and Doctorate of Pharmacy degrees from the University of Michigan in Ann Arbor, MI. She completed residency training at Ascension St. Vincent Anderson in Anderson, IN during which time she also earned a teaching certificate from Purdue University College of Pharmacy. Dr. Shiravanthe is Board Certified in Pharmacotherapy (BCPS) and is a licensed pharmacist in Indiana and California. Prior to joining Otsuka, Dr. Shiravanthe worked as a clinical pharmacist at Ascension St. Vincent Anderson for 2.5 years, and as a clinical pharmacy specialist at the Department of Veterans Affairs Palo Alto Healthcare System for 3 years. During this time, she also served as a preceptor for the pharmacy residency program clinical teaching skills, grand rounds, and clinical research rotations. Her clinical practice experience includes internal medicine, cardio-renal diseases, infectious diseases, and geriatrics.

Dr. Sushma Shiravanthe and Marla Dallal are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. 

Dr. Niloofar Nobakht is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.

The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.
July 2024    US.CORP.X.24.00216

Registration

Related Resources

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.